BioSpace News Archive

Oncology Practice/Clinical Research Management Company Builds Practices in Nashville and Dallas

Appoints Dr. Sherron Kell as SVP of Clinical Development and Program Lead for PRV-031 (Teplizumab)

Canopy Growth recently retrofitted the now fully licensed KeyLeaf facility in Saskatchewan, a company with over 50 years of experience in the extraction industry.

The objective of this study is to evaluate the effectiveness of providing daily doses of QuickStrip™ Vitamin B12 oral thin film strips to Inflammatory Bowel Disease patients who are vitamin B12 deficient.

DAPA-HF is the first heart failure outcomes trial with an SGLT2 inhibitor in patients with and without type 2 diabetes

The trial will take place at the Aflac Cancer and Blood Disorders Center at Children’s Healthcare of Atlanta.

Soliton, Inc., (NASDAQ:SOLY) (“Soliton” or the “Company”), today announced results of preclinical studies which reveal its RAP device appears to deliver increased disruption of the fibrotic septa that contribute to the appearance of cellulite with increased treatment time, implying a dose response to the therapy.

Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, today announced that the Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for peginterferon lambda (Lambda) for the treatment of hepatitis delta virus (HDV) infection.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) for the VX-445 (elexacaftor), tezacaftor and ivacaftor triple combination regimen.

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today announced that members of Lineage’s executive leadership team and Board of Directors will ring The Opening Bell® at the New York Stock Exchange (NYSE) on Wednesday, August 21, 2019.